Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
glypican 5 | 0.626 | 0.654 | 4.0E-10 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2018 | 2019 | ||||||||
|
N-acylethanolamine acid amidase | 0.579 | 0.692 | 2.1E-10 |
|
phenotype | 0.100 | None | 1.000 | 3 | 6 | 2018 | 2019 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.100 | None | 1.000 | 3 | 22 | 2018 | 2019 | |||||||||
|
histidine rich glycoprotein | 0.603 | 0.577 | 5.9E-14 |
|
phenotype | 0.100 | None | 1.000 | 3 | 16 | 2018 | 2019 | ||||||||
|
apolipoprotein E | 0.338 | 0.962 | 1.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 3 | 2 | 2018 | 2018 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 4 | 2018 | 2018 | ||||||||
|
contactin 5 | 0.695 | 0.462 | 6.2E-05 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2018 | 2019 | ||||||||
|
N-acylsphingosine amidohydrolase 2 | 0.716 | 0.538 | 4.3E-03 |
|
phenotype | 0.100 | None | 1.000 | 3 | 7 | 2018 | 2019 | ||||||||
|
selectin P | 0.460 | 0.769 | 5.0E-32 |
|
phenotype | 0.100 | None | 1.000 | 3 | 5 | 2018 | 2018 | ||||||||
|
ADAM metallopeptidase domain 23 | 0.650 | 0.500 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 3 | 5 | 2018 | 2019 | ||||||||
|
kynureninase | 0.617 | 0.692 | 4.2E-18 |
|
phenotype | 0.100 | None | 1.000 | 3 | 3 | 2018 | 2019 | ||||||||
|
Wilms tumor 1 associated protein pseudogene 1 | 0.890 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 2 | 7 | 2018 | 2018 | |||||||||
|
CBR3 antisense RNA 1 | 0.705 | 0.231 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2018 | |||||||||
|
NAGPA antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 2 | 1 | 2018 | 2018 | |||||||||||
|
CPB2 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 2 | 9 | 2018 | 2018 | |||||||||||
|
BLOC1S5-TXNDC5 readthrough (NMD candidate) |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2018 | |||||||||||
|
MIA-RAB4B readthrough (NMD candidate) | 0.821 | 0.385 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2018 | |||||||||
|
plexin C1 | 0.722 | 0.269 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 2 | 4 | 2018 | 2018 | ||||||||
|
cholesterol induced regulator of metabolism RNA | 0.861 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2018 | |||||||||
|
ROR1 antisense RNA 1 | 0.751 | 0.192 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2018 | |||||||||
|
reactive intermediate imine deaminase A homolog | 0.606 | 0.769 | 6.8E-02 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2018 | ||||||||
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 | 0.821 | 0.231 | 2.3E-08 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2018 | 2018 | ||||||||
|
spondin 1 | 0.705 | 0.385 |
|
phenotype | 0.100 | None | 1.000 | 2 | 3 | 2018 | 2018 | |||||||||
|
peptidylprolyl isomerase E | 0.861 | 0.269 | 0.73 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2018 | 2018 | ||||||||
|
glycoprotein nmb | 0.566 | 0.692 | 2.9E-27 |
|
phenotype | 0.100 | None | 1.000 | 2 | 5 | 2018 | 2018 |